Annual CFI
-$88.13 M
-$57.03 M-183.40%
31 December 2022
Summary:
Provention Bio annual cash flow from investing activities is currently -$88.13 million, with the most recent change of -$57.03 million (-183.40%) on 31 December 2022. During the last 3 years, it has fallen by -$113.30 million (-450.07%).PRVB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$51.27 M
-$5.04 M-10.91%
31 December 2022
Summary:
Provention Bio quarterly cash flow from investing activities is currently -$51.27 million, with the most recent change of -$5.04 million (-10.91%) on 31 December 2022.PRVB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$88.13 M
-$13.58 M-18.22%
31 December 2022
Summary:
Provention Bio TTM cash flow from investing activities is currently -$88.13 million, with the most recent change of -$13.58 million (-18.22%) on 31 December 2022.PRVB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRVB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -450.1% | -497.3% | -695.6% |
| 5 y5 years | -100.0% | -100.0% | -100.0% |
PRVB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -450.1% | -494.4% | -450.1% |
Provention Bio Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$88.13 M(+183.4%) | -$51.27 M(+10.9%) | -$88.13 M(+18.2%) |
| Sept 2022 | - | -$46.23 M(>+9900.0%) | -$74.55 M(+383.7%) |
| June 2022 | - | -$226.00 K(-102.4%) | -$15.41 M(+12.8%) |
| Mar 2022 | - | $9.60 M(-125.5%) | -$13.67 M(-56.0%) |
| Dec 2021 | -$31.10 M(-223.5%) | -$37.69 M(-392.1%) | -$31.10 M(-310.2%) |
| Sept 2021 | - | $12.91 M(+750.2%) | $14.79 M(-1462.3%) |
| June 2021 | - | $1.52 M(-119.4%) | -$1.09 M(-110.4%) |
| Mar 2021 | - | -$7.83 M(-195.5%) | $10.40 M(-58.7%) |
| Dec 2020 | $25.17 M | $8.20 M(-375.6%) | $25.17 M(-186.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$2.98 M(-122.9%) | -$29.27 M(+11.3%) |
| June 2020 | - | $13.00 M(+87.0%) | -$26.30 M(-33.1%) |
| Mar 2020 | - | $6.95 M(-115.0%) | -$39.30 M(-15.0%) |
| Dec 2019 | -$46.25 M(<-9900.0%) | -$46.25 M(<-9900.0%) | -$46.25 M(<-9900.0%) |
| Sept 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Provention Bio annual cash flow from investing activities?
- What is the all time high annual CFI for Provention Bio?
- What is Provention Bio quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Provention Bio?
- What is Provention Bio TTM cash flow from investing activities?
- What is the all time high TTM CFI for Provention Bio?
What is Provention Bio annual cash flow from investing activities?
The current annual CFI of PRVB is -$88.13 M
What is the all time high annual CFI for Provention Bio?
Provention Bio all-time high annual cash flow from investing activities is $25.17 M
What is Provention Bio quarterly cash flow from investing activities?
The current quarterly CFI of PRVB is -$51.27 M
What is the all time high quarterly CFI for Provention Bio?
Provention Bio all-time high quarterly cash flow from investing activities is $13.00 M
What is Provention Bio TTM cash flow from investing activities?
The current TTM CFI of PRVB is -$88.13 M
What is the all time high TTM CFI for Provention Bio?
Provention Bio all-time high TTM cash flow from investing activities is $25.17 M